Sign in

CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Design Therapeutics, Inc.

Sign in to watch
Ticker
DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823929248
Phone
858-293-4900
Business address
6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-30 LAPPE RODNEY W Director Purchase +5,000 $20.00 $100K 97,024
2021-03-30 Shah Pratik Executive Chairperson Purchase +25,000 $20.00 $500K 25,000
2021-03-30 Shah Pratik Executive Chairperson Conversion +104,923 129,923
2021-03-30 Shah Pratik Executive Chairperson Conversion · Series A Preferred Stock −171,025 0
2021-03-30 Thacker Justin Vice President, Finance Purchase +17,500 $20.00 $350K 17,500
2021-03-30 William Arsani Director Conversion +1,217,627 1,217,627
2021-03-30 William Arsani Director Conversion +814,874 2,032,501
2021-03-30 William Arsani Director Purchase +700,000 $20.00 $14.0M 2,732,501
2021-03-30 William Arsani Director Conversion · Series B Preferred Stock −1,984,733 0
2021-03-30 William Arsani Director Conversion · Series B Preferred Stock −1,328,245 0
2021-03-25 Xu Stella Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-03-25 William Arsani Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-03-25 Schmid John P. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-03-25 LAPPE RODNEY W Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-03-25 George Simeon Director Grant or award · Stock Option (right to buy) +15,000 15,000

Page 7 of 7 · 135 trades